-
Panelists Explain ACR’s Expanding JIA Guidelines
Experts from the ACR’s juvenile idiopathic arthritis (JIA) guideline team, including Susan Shenoi, MBBS, MS, RhMSUS, reviewed key recommendations and changes in response to new therapeutic advances and emerging challenges. The now 15 recommendations for systemic JIA, for example, reflect greater stratification based on clinical presentation.
More news from #ACR25
-
Hench Lecture Traces IgG4-RD History, Quest for Therapies
While honoring rheumatology pioneer Philip Hench, John Stone, MD, MPH, discussed the groundbreaking work that has furthered the understanding and treatment of IgG4-related disease, including the approval of a monoclonal antibody that depletes CD19-positive B cells for use in adults.
-
FDA Reviews New Approvals, Safety Concerns for Rheumatologic Drugs
During ACR Convergence 2025, representatives from the U.S. Food and Drug Administration detailed the latest approvals of rheumatologic drugs, along with safety updates and considerations for T cell engagers.
ACR Convergence Newsmakers
-
FDA Pediatric Rheumatology Update Reviews New Drug Approvals
Emily C. Gotschlich, MD, gave an overview of several new indications for pediatric rheumatology, including in pediatric psoriatic arthritis, pediatric lupus nephritis, and systemic juvenile idiopathic arthritis. Most approvals leveraged an extrapolation approach, allowing efficacy data from adult populations to support pediatric indications when disease similarity was established.
-
Experts Share Clinical Pearls for Recognizing and Managing POTS and Overlapping Syndromes
Speakers, including Brittany Adler, MD, discussed how postural orthostatic tachycardia syndrome (POTS) and related autonomic disorders have emerged as increasingly prevalent and complex conditions, as well as the role of physical therapy in POTS management.
-
Presenters Discuss Oral Manifestations of SSc and Sjögren’s Disease
Better oral health translates into better rheumatic health for patients living with both of these conditions, explained Natalia Trehan, DMD, one of the featured experts in a session on the orofacial complications of systemic sclerosis and Sjögren’s disease.
Poster Spotlights
